Hoffman William's Form 4 filing
Inari Medical, Inc. (NARI) · filed Jun 20, 2024
- Accession no.
- 0001127602-24-019003
- Filed
- Jun 20, 2024
- Trade date
- Jun 17, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.74M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hoffman WilliamCIK 0001304099 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 17, 2024 | Common Stock | SSaleDisposed | −31,600 | $43.31 | −$1,368,596 | 833,759 | Direct | |
| Jun 17, 2024 | Common Stock | SSaleDisposed | −6,175 | $44.16 | −$272,688 | 827,584 | Direct | |
| Jun 17, 2024 | Common Stock | SSaleDisposed | −2,125 | $45.04 | −$95,710 | 825,459 | Direct | |
| Jun 17, 2024 | Common Stock | SSaleDisposed | −100 | $45.85 | −$4,585 | 825,359 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.